Literature DB >> 17035817

Antibiotic efflux mechanisms.

H Nikaido1, H I Zgurskaya.   

Abstract

Bacterial genomes sequenced to date almost invariably contain genes apparently coding for multidrug efflux pumps, and the yeast genome contains more than 30 putative multidrug efflux genes. Thus it is not surprising that multidrug efflux is a major cause of intrinsic drug resistance in many microorganisms, and plays an even more prominent role in organisms with a low-permeability cell wall, such as Gram negative bacteria in general and Pseudomonas aeruginosa in particular, as well as Mycobacterium species. Furthermore, overproduction of intrinsic pumps, or acquisition of pump genes from external sources, often results in high levels of resistance. This review discusses the classification of efflux proteins, their mechanism of action, the regulation of their expression, and the clinical significance of efflux pumps.

Entities:  

Year:  1999        PMID: 17035817     DOI: 10.1097/00001432-199912000-00001

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  28 in total

Review 1.  Molecular basis of bacterial outer membrane permeability revisited.

Authors:  Hiroshi Nikaido
Journal:  Microbiol Mol Biol Rev       Date:  2003-12       Impact factor: 11.056

2.  Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.

Authors:  Christopher A Elkins; Lisa B Mullis
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

Review 3.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

4.  Funnel-like hexameric assembly of the periplasmic adapter protein in the tripartite multidrug efflux pump in gram-negative bacteria.

Authors:  Yongbin Xu; Minho Lee; Arne Moeller; Saemee Song; Bo-Young Yoon; Hong-Man Kim; So-Young Jun; Kangseok Lee; Nam-Chul Ha
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

5.  Structure of the tripartite multidrug efflux pump AcrAB-TolC suggests an alternative assembly mode.

Authors:  Jin-Sik Kim; Hyeongseop Jeong; Saemee Song; Hye-Yeon Kim; Kangseok Lee; Jaekyung Hyun; Nam-Chul Ha
Journal:  Mol Cells       Date:  2015-01-15       Impact factor: 5.034

Review 6.  SecA: a potential antimicrobial target.

Authors:  Arpana S Chaudhary; Weixuan Chen; Jinshan Jin; Phang C Tai; Binghe Wang
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

7.  Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It.

Authors:  Helen I Zgurskaya; Cesar A Löpez; S Gnanakaran
Journal:  ACS Infect Dis       Date:  2015       Impact factor: 5.084

8.  Using Chemical Probes to Assess the Feasibility of Targeting SecA for Developing Antimicrobial Agents against Gram-Negative Bacteria.

Authors:  Jinshan Jin; Ying-Hsin Hsieh; Jianmei Cui; Krishna Damera; Chaofeng Dai; Arpana S Chaudhary; Hao Zhang; Hsiuchin Yang; Nannan Cao; Chun Jiang; Martti Vaara; Binghe Wang; Phang C Tai
Journal:  ChemMedChem       Date:  2016-10-18       Impact factor: 3.466

Review 9.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Role of the Tet38 Efflux Pump in Staphylococcus aureus Internalization and Survival in Epithelial Cells.

Authors:  Q C Truong-Bolduc; G R Bolduc; H Medeiros; J M Vyas; Y Wang; D C Hooper
Journal:  Infect Immun       Date:  2015-08-31       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.